Phase II trial of menogaril in adenocarcinoma of the pancreas. A Southwest Oncology Group study.
Brown
T D
TD
University of Texas Health Science Center, San Antonio.
Goodman
P J
PJ
Fleming
T R
TR
Baker
L H
LH
Macdonald
J S
JS
D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D017290:Menogaril; D008875:Middle Aged; D009621:Nogalamycin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010190:Pancreatic Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D017290:Menogaril; D009621:Nogalamycin